Searching journal content for articles similar to Zhao et al. 57 (1): R19.

Displaying results 1-10 of 15
For checked items
  1. ...15–R31 Correspondence should be addressed to S Mader Email [email protected] Key Words f breast cancer f estrogen receptors f antiestrogens f SUMOylation f ubiquitination DOI: 10.1530/JME-16-0024 http://.endocrinology-journals.org © 2017 The authors Printed in Great Britain Published...
  2. ...be mediated through its anti-estrogenic actions as well as its role in regulating the activity of aromatases, the enzymes responsible for the local biosynthesis of estrogens from androgens (Cos et al. 2006). Recent studies using MCF-7 breast cancer xenografts in mice showed that suppression of melatonin...
  3. ...K, Tournigand C, Decleves X, de Cremoux P et al. 2014 Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study. Journal of Pain 15 293–303. (doi:10.1016/j.jpain.2013...
  4. ...primarily to postmenopausal and breast cancer risk is more controversial (Cheraghi et al. ld 2013). This is largely due to overall adiposity rather than ts. More recently, waist-to-hip Thematic Review E R SIMPSON and K A BROWN Obesity, inflammation and aromatase 51 :3 T51–T59and renal failure. What is less...
  5. ...et al. 2010), demonstrate that women taking progestins added to estrogen therapy are at greater risk of developing breast tumors. Unexpectedly, estrogen alone as a single-agent therapy for women who have had a hysterectomy confers protection against breast cancer (hazard ratio 0.77; 95% CI 0...
  6. ...with early-stage breast cancer treated with chemotherapy and an aromatase inhibitor, who exhibited poorer executive function including working memory and concentration (Bender et al. 2015).(Agarwal et al. 1998). This resulted in short stature due to Published by Bioscientifica Ltd. proportion to adiposity...
  7. ...)-driven luciferase reporter assay in GT1-7 mouse hypothalamic neuronal cells to a similar extent as 10 nM E2, suggesting ~1000-fold lower affinity (Bruder et al. 1997). DHEA did not appear to be metabolized to E2 in the GT1-7 cells. In MCF-7 and MCF-7SH (an estrogen nonresponsive subline) breast cancer cells...
  8. ...breast cancer treated with aromatase inhibitors. Oncology 79 55–61. (doi:10.1159/000319540) Murphy LC, Niu Y, Snell L & Watson P 2004 Phospho-serine-118 estrogen receptor-a expression is associated with better disease outcome in women treated with tamoxifen. Clinical Cancer Research 10 5902–5906. (doi:10...
  9. ...; ii) the absence of several KLFs in distinct pathologies (e.g. KLF9 and KLF4 in endometrial cancer and endometriosis; KLF9 and KLF11 in endometriosis and leiomyoma) indicates roles for multiple KLFs in maintainLF e Ref Sim Sim Yoo KLF6 (h) Y DiF KLF9 (h) Y/[ Hu Yan Lee Daf Rac Yin Sun Sim Zen Review R...
  10. ...that only circulating estradiol, whether secreted by the ovary or formed in the adipose tissue, could exert an estrogenic effect after delivery to target tissues via the bloodstream. Studies on aromatase expression in breast cancer demonstrated that paracrine mechanisms play an important role in estrogen...
For checked items